Plasmin not only functions as a key enzyme in the fibrinolytic system but also directly inactivates factor VIII and other clotting factors such as factor V. However, the mechanisms of plasmincatalyzed factor VIII inactivation are poorly understood. In this study, levels of factor VIII activity increased ϳ2-fold within 3 min in the presence of plasmin, and subsequently decreased to undetectable levels within 45 min. This time-dependent reaction was not affected by von Willebrand factor and phospholipid. The rate constant of plasmin-catalyzed factor VIIIa inactivation was ϳ12-and ϳ3.7-fold greater than those mediated by factor Xa and activated protein C, respectively. SDS-PAGE analysis showed that plasmin cleaved the heavy chain of factor VIII into two terminal products, A1 Factor VIII, a plasma protein deficient or defective in individuals with the severe congenital bleeding disorder hemophilia A, functions as a cofactor in the tenase complex, which is responsible for anionic phospholipid surface-dependent conversion of factor X to Xa by factor IXa (1). Factor VIII circulates as a complex with VWF 2 that protects and stabilizes the cofactor. Factor VIII is synthesized as a single chain molecule consisting of 2,332 amino acid residues with a molecular mass of ϳ300 kDa (2, 3). The factor VIII molecule can be divided into three domains arranged in the order of A1-A2-B-A3-C1-C2 according to the amino acid content homology. It is processed into a series of metal ion-dependent heterodimers by cleavage at the B-A3 junction, generating a heavy chain consisting of the A1 and A2 domains, plus heterogeneous fragments of a partially proteolyzed B domain, linked to a light chain consisting of the A3, C1, and C2 domains (2-4). The catalytic efficacy of factor VIII in the tenase complex is enhanced over 10 5 times by conversion into an active form, factor VIIIa, by limited proteolysis by either thrombin or factor Xa (5). Both enzymes cleave factor VIII at Arg 372 and Arg 740 of the heavy chain and produce 50-kDa A1 and 40-kDa A2 subunits. The 80-kDa light chain is also cleaved at Arg 1689 generating a 70-kDa A3-C1-C2 subunit. Additionally, factor Xa cleaves at Arg 1721 and produces a 67-kDa A3-C1-C2 subunit. Proteolysis at Arg 372 and Arg 1689 is essential for generating factor VIIIa cofactor activity (6). Cleavage at the former site exposes a functional factor IXa-interactive site within the A2 domain that is cryptic in the unactivated molecule (7). Cleavage at the latter site liberates the cofactor from its carrier protein, VWF (8), contributing to the overall specific activity of the cofactor (9, 10).Factor VIIIa cofactor activity is down-regulated in the presence of serine proteases such as APC (5), factor Xa (5), and factor IXa (11) by proteolytic inactivation following cleavage at Arg 336 within the A1 subunit. This inactivation appears to be the result of altered interaction with the A2 subunit and an increased K m value of the truncated A1 for the substrate factor X (12, 13), the latter reaction reflecting loss of a fac...